Discovery of a novel TLR2 signaling inhibitor with anti-viral activity.

[1]  J. Hoofnagle,et al.  Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. , 2009, Gastroenterology.

[2]  R. Finberg,et al.  Antiviral responses: different roles for different tolls. , 2009, Immunity.

[3]  Michael Czarniecki,et al.  Small Molecule Modulators of Toll-Like Receptors , 2009 .

[4]  K. Honda,et al.  Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. , 2009, Blood.

[5]  Osamu Takeuchi,et al.  Innate immunity to virus infection , 2009, Immunological reviews.

[6]  L. Anderson,et al.  Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2 , 2008, Journal of Virology.

[7]  D. Smee,et al.  Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin , 2008, PloS one.

[8]  D. Golenbock,et al.  Lymphocytic Choriomeningitis Virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses , 2008, Journal of Neuroimmunology.

[9]  A. Smahi,et al.  TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.

[10]  M. Mizuno,et al.  Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice. , 2007, European journal of pharmacology.

[11]  E. Kurt-Jones,et al.  Innate immunity to respiratory viruses , 2007, Cellular microbiology.

[12]  L. O’Neill,et al.  Targeting signal transduction as a strategy to treat inflammatory diseases , 2006, Nature Reviews Drug Discovery.

[13]  Lena Alexopoulou,et al.  Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia , 2006, PLoS pathogens.

[14]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[15]  G. Jung,et al.  Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships. , 2006, Journal of medicinal chemistry.

[16]  M. Yamada,et al.  Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate. , 2005, Journal of medicinal chemistry.

[17]  D. Golenbock,et al.  MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection , 2005, European journal of immunology.

[18]  S. Akira,et al.  Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 , 2005, Nature Medicine.

[19]  E. Kurt-Jones,et al.  Viruses and Toll-like receptors. , 2004, Microbes and infection.

[20]  Peter B Jahrling,et al.  Exotic emerging viral diseases: progress and challenges , 2004, Nature Medicine.

[21]  E. Fikrig,et al.  Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis , 2004, Nature Medicine.

[22]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[23]  R. Bronson,et al.  Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[25]  D. Golenbock,et al.  Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2 , 2003, Journal of Virology.

[26]  Dirk E. Smith,et al.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.

[27]  Douglas T. Golenbock,et al.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.

[28]  C. Janeway,et al.  The Toll receptor family and microbial recognition. , 2000, Trends in microbiology.

[29]  R M Zinkernagel,et al.  Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.

[30]  M. Pagano,et al.  Hypothesis tests. , 1993, Nutrition.